Insulet stock trades 60.9 percent below its 52-week high
Published on 09/23/2026 at 16:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Insulet stock was trading at USD 138.84 on Nasdaq on September 23, 2026, at 10:25 a.m. ET, 60.9 percent below its 52-week high of USD 354.88. Management is scheduled to present at the Bernstein Insights Healthcare Forum on September 24, 2026, according to Business Wire.
Revenue clears second quarter guidance
Insulet generated USD 801.7 million in second-quarter 2026 revenue, an increase of 22.7 percent on a constant currency basis. The figure exceeded management's guidance range of 20 percent to 22 percent, according to The Globe and Mail.
Adjusted EPS reached USD 1.66 in Q2 2026, up 41.5 percent from USD 1.17 in the prior-year quarter. Insulet's operating profit was USD 129.7 million, while operating margin was 16 percent in the same period.
Guidance splits the growth picture
Insulet kept full-year 2026 constant currency revenue growth guidance at 20 percent to 22 percent. The company lowered its U.S. Omnipod growth outlook to 17 percent to 19 percent, while international Omnipod guidance increased to 30 percent to 32 percent, according to The Globe and Mail.
The split matters because international expansion is offsetting a more cautious U.S. trajectory. Insulet also raised its full-year adjusted EPS growth outlook to at least 30 percent from more than 25 percent, pointing to operating leverage alongside the revenue plan.
Stock remains below yearly high
At USD 138.84, the stock was down 0.39 percent during the September 23 session. The market capitalization stood at USD 9,616,707,338, giving the valuation a direct connection to the company's revenue growth and revised regional outlook.
Insulet market profile
- Company: Insulet Corporation
- Ticker: PODD
- Trading venue: Nasdaq
- Price as of September 23, 2026, 10:25 a.m. ET: USD 138.84
- Market capitalization: USD 9,616,707,338 as of September 23, 2026
- 52-week range: USD 126.40-354.88 as of September 23, 2026
- Sector / Industry: Healthcare / Medical Devices
